These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6267670)
1. Cardiovascular actions of angiotensin in the fowl (Gallus domesticus). II. Angiotensin analog agonists and antagonists. Moore AF; Strong JH; Buckley JP Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):447-57. PubMed ID: 6267670 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular actions of angiotensin in the fowl (Gallus domesticus). I. Analysis. Moore AF; Strong JH; Buckley JP Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):423-45. PubMed ID: 7268192 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin antagonists with increased specificity for the renal vasculature. Taub KJ; Caldicott WJ; Hollenberg NK J Clin Invest; 1977 Mar; 59(3):528-35. PubMed ID: 190270 [TBL] [Abstract][Full Text] [Related]
4. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats. Campbell WB; Schmitz JM; Itskovitz HD Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407 [TBL] [Abstract][Full Text] [Related]
5. Antagonists, inhibitors and antisera in the evaluation of vascular renin activity. The role of local generation of angiotensin II. Swales JD Prog Biochem Pharmacol; 1976; 12():98-113. PubMed ID: 798204 [TBL] [Abstract][Full Text] [Related]
6. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats. Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530 [TBL] [Abstract][Full Text] [Related]
7. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin. Abhold RH; Sullivan MJ; Wright JW; Harding JW J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120 [TBL] [Abstract][Full Text] [Related]
8. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues. Pendleton RG; Gessner G; Horner E J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998 [TBL] [Abstract][Full Text] [Related]
9. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II. Hepp R; Grillet C; Peytremann A; Vallotton MB Prog Biochem Pharmacol; 1976; 12():41-8. PubMed ID: 1019169 [TBL] [Abstract][Full Text] [Related]
10. Pressor and stereoidogenic actions of [des-Asp1]angiotensin I dependency on conversion to angiotensin III. Vaughan ED; Peach MJ; Ackerly JA; Tsai BS; Larner A Circ Res; 1977 May; 40(5 Suppl 1):I94-7. PubMed ID: 858177 [TBL] [Abstract][Full Text] [Related]
11. Will chronic intracerebroventricular saralasin infusion produce selective blockade of brain angiotensin II receptors in the rat? Bruner CA; Weaver JM; Fink GD J Pharmacol Exp Ther; 1983 Jul; 226(1):13-8. PubMed ID: 6306220 [TBL] [Abstract][Full Text] [Related]
12. Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta. Pendleton RG; Gessner G; Horner E J Pharmacol Exp Ther; 1989 Feb; 248(2):637-43. PubMed ID: 2918473 [TBL] [Abstract][Full Text] [Related]
13. Biphasic blood pressure response to angiotensin II in the conscious rabbit: relation to prostaglandins. Rowe BP; Nasjletti A J Pharmacol Exp Ther; 1983 Jun; 225(3):559-63. PubMed ID: 6575174 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension. Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and metabolic effects of angiotensin II on the liver. Nascimento EA; Gioli-Pereira L; Carvalho LT; Santos EL; Pesquero JB; Kouyoumdjian M; Borges DR Peptides; 2005 Feb; 26(2):315-22. PubMed ID: 15629544 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats. Tarpey SB; Bennett T; Randall MD; Gardiner SM Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732 [TBL] [Abstract][Full Text] [Related]
17. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats. Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of angiotensin III in brainstem nuclei of normotensive and hypertensive rats. Tseng CJ; Chou LL; Ger LP; Tung CS J Pharmacol Exp Ther; 1994 Feb; 268(2):558-64. PubMed ID: 8113967 [TBL] [Abstract][Full Text] [Related]
19. Blockade of the pressor response to angiotensins I and II in the bullfrog, Rana catesbeiana. Harper RA; Stephens GA Gen Comp Endocrinol; 1985 Nov; 60(2):227-35. PubMed ID: 3905501 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats. Lark LA; Wappel SM; Weyhenmeyer JA J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]